Q32 Bio (QTTB) Return on Capital Employed Growth (3y) (2021 - 2026)
Q32 Bio (QTTB) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | 9,406.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,406.00 |
| Dec 31, 2025 | 9,467.00 |
| Sep 30, 2025 | -3,225.00 |
| Jun 30, 2025 | -4,265.00 |
| Mar 31, 2025 | -3,420.00 |
| Dec 31, 2024 | -3,362.00 |
| Sep 30, 2024 | -3,666.00 |
| Jun 30, 2024 | -1,533.00 |
| Mar 31, 2024 | -4,249.00 |
| Dec 31, 2023 | -242.00 |
| Sep 30, 2023 | 1,173.00 |
| Jun 30, 2023 | -23.00 |
| Mar 31, 2023 | -994.00 |
| Dec 31, 2022 | -2,328.00 |
| Sep 30, 2022 | -1,961.00 |
| Jun 30, 2022 | -1,427.00 |
| Mar 31, 2022 | -2,252.00 |
| Dec 31, 2021 | -2,218.00 |
| Sep 30, 2021 | -1,999.00 |
| Jun 30, 2021 | -1,669.00 |